Mayo T, Armstrong AW, Kircik L, Silverberg JI, Blauvelt A, Esdalie B, Schneider S, Mark T, Gooderham M, Alexis AF. Efficacy and safety of tralokinumab treatment in adults of different racial subgroups with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled phase 3 trials. J of Skin [Internet]. 2022 Nov. 16 [cited 2024 Jul. 3];6(6):s76. Available from: https://jofskin.org/33014/index.php/skin/article/view/1834